In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
D000328:Adult; D001260:Ataxia Telangiectasia / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D002908:Chronic Disease; D004062:DiGeorge Syndrome / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D013947:Thymosin / Q000627:therapeutic use*; D013950:Thymus Gland / Q000002:abnormalities; D013951:Thymus Hormones / Q000627:therapeutic use*; D014923:Wiskott-Aldrich Syndrome / Q000188:drug therapy
D007136:Immunoglobulins; D013951:Thymus Hormones; D013947:Thymosin